You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!
GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). Read More The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Middlesex, Greater London
52 Week High
52 Week Low
Global Amyloidosis Market Spotlight 2020: GlaxoSmithKline has the Highest Number of Completed Clinical Trials for Amyloidosis, with Five Trials
DUBLIN, Sept. 14, 2020 /PRNewswire/ -- The "Market Spotlight: Amyloidosis" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight re
— per share
Available Oct 28